François-Henri BOISSEL introducing NOVA at Labiotech Refresh 2017, Berlin.
The Effect Model enables us -according to the indicators that you have, either clinical, genetic, imaging or biomarkers, – to go down to the patient and to go much further in an individual prescription.
François-Henri BOISSEL introducing NOVA at 17th Biotech in Europe Forum – Sachs Associates
The human body contains 10 000 potential targets. that means that we are just at the begining and there is a huge of fields to be explored with the right tools to investigate in a capital efficient maner.
Boissel JP, Auffray C, Denis Noble, Hood L, Boissel FH | CPT Pharmacometrics Syst. Pharmacol 2015; 4, e26